Your browser doesn't support javascript.
loading
IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment.
Tiburcio, Patricia D B; Xiao, Bing; Chai, Yi; Asper, Sydney; Tripp, Sheryl R; Gillespie, David L; Jensen, Randy L; Huang, L Eric.
Afiliação
  • Tiburcio PDB; Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.
  • Xiao B; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Chai Y; Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.
  • Asper S; Department of Neurosurgery, Nanchang University Second Affiliated Hospital, Nanchang, Jiangxi, People's Republic of China.
  • Tripp SR; Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.
  • Gillespie DL; Department of Neurosurgery, Nanchang University Second Affiliated Hospital, Nanchang, Jiangxi, People's Republic of China.
  • Jensen RL; Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.
  • Huang LE; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA.
Oncotarget ; 9(80): 35100-35113, 2018 Oct 12.
Article em En | MEDLINE | ID: mdl-30416682

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos